Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAM conditioning for ASCT in lymphoma
NCT03346096Phase 2Completed
- Sponsor
- Sheba Medical Center
- Start
- Oct 2018
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), sponsored by Sheba Medical Center. Started Oct 2018; status: completed.
02
Drugs
thiotepa
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT03346096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03346096.